Bacterial resistance mechanisms against host defense peptides

Cellular and Molecular Life Sciences

Volumn 68, Issue 13, 2011, Pages 2243-2254

  Koprivnjak, Tomaz ^a   Peschel, Andreas ^b  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Aminoarabinose; Cationic peptides; D alanylation; Ethanolamine; Lipid A; Multidrug efflux pumps; Pathogens; Proteases; Teichoic acids

Indexed keywords

ADHESIN; ALANINE; ALPHA DEFENSIN; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; BAMBERMYCIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYCLIC AMP; DAPTOMYCIN; DERMCIDIN; ELASTASE; GENTAMICIN; LIPID A; LYSINE; MULTIDRUG RESISTANCE PROTEIN; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPASE A2; PROTEIN APSRSX; PROTEIN DLTA; PROTEIN GRARSX; PROTEIN MPRF; PROTEIN PMRA; PROTEIN PMRD; STAPHYLOKINASE; TEICHOIC ACID; UNCLASSIFIED DRUG; VANCOMYCIN;

ALPHA HELIX; AMINO ACID COMPOSITION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; APOPTOSIS; AUTOIMMUNITY; BACILLUS SUBTILIS; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BETA SHEET; CELL SURFACE; DISULFIDE BOND; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME BINDING; ENZYME INACTIVATION; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MEMBRANE FLUIDITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEISSERIA GONORRHOEAE; NONHUMAN; OPERON; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; UPREGULATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE;

BACTERIA (MICROORGANISMS);

EID: 79960938721     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0716-4     Document Type: Review

References (148)

1. Weiss J, Bayer AS, Yeaman M (2006) Cellular and extracellular defenses against Staphylococcal infections. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds) Gram-positive pathogens. ASM Press, Washington, DC
2. DeLeo FR, Diep BA, Otto M (2009) Host defense and pathogenesis in Staphylococcus aureus infections. Infect Dis Clin North Am 23:17-34
3. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801 (Pubitemid 43261452)
4. Lehrer RI (2004) Primate defensins. Nat Rev Microbiol 2:727-738
5. Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720
6. Easton DM, Nijnik A, Mayer ML, Hancock REW (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 27:582-590
7. Peschel A, Sahl H-G (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Micro 4:529-536 (Pubitemid 43905612)
8. Izadpanah A, Gallo RL (2005) Antimicrobial peptides. J Am Acad Dermatol 52:381-390 quiz 391-382
9. Lehrer RI, Ganz T (2002) Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol 9:18-22 (Pubitemid 34025307)
10. Ayabe T (2000) Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nature Immunol 1:113-118
11. Bals R (1999) Mouse [beta]-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun 67:3542-3547
12. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG (1995) hBD-1: a novel [beta]-defensin from human plasma. FEBS Lett 368:331-335
13. Yeaman MR (2010) Platelets in defense against bacterial pathogens. Cell Mol Life Sci 67:525-544
14. Fitzgerald JR, Foster TJ, Cox D (2006) The interaction of bacterial pathogens with platelets. Nat Rev Micro 4:445-457 (Pubitemid 43771864)
15. Bayer AS, Cheng D, Yeaman MR, Corey GR, McClelland RS, Harrel LJ, Fowler VG Jr (1998) In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source. Antimicrob Agents Chemother 42:3169-3172
16. Kupferwasser LI, Yeaman MR, Shapiro SM, Nast CC, Bayer AS (2002) In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses. Circulation 105:746-752
17. Dhawan VK, Bayer AS, Yeaman MR (1998) In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis. Infect Immun 66:3476-3479
18. Ganz T (2006) Hepcidin-a peptide hormone at the interface of innate immunity and iron metabolism. Curr Top Microbiol Immunol 306:183-198
19. Madhuri ST, Venugopal SK, Ghosh D, Gadepalli R, Dhawan B, Mukhopadhyay K (2009) In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus. Peptides 30:1627-1635
20. Schneider T, Gries K, Josten M, Wiedemann I, Pelzer S, Labischinski H, Sahl HG (2009) The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate. Antimicrob Agents Chemother 53:1610-1618
21. Sass V, Schneider T, Wilmes M, Korner C, Tossi A, Novikova N, Shamova O, Sahl H-G (2010) Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci. Infect Immun 78:2793-2800
22. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Jansen A, Nielsen AK, Mygind PH, Raventos DS, Neve S, Ravn B, Bonvin AMJJ, De Maria L, Andersen AS, Gammelgaard LK, Sahl H-G, Kristensen H-H (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 328:1168-1172
23. Lai Y, Gallo RL (2009) AMPed Up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30:131-141
24. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395
25. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462:55-70
26. Wimley WC, Selsted ME, White SH (1994) Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci 3:1362-1373 (Pubitemid 24314455)
27. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR (2000) Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol (Baltimore, MD, 1950) 164:549-553
28. Durr M, Peschel A (2002) Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 70:6515-6517 (Pubitemid 35387875)
29. Mader JS, Marcet-Palacios M, Hancock REW, Bleackley RC (2011) The human cathelicidin, LL-37, induces granzyme-mediated apoptosis in cytotoxic T lymphocytes. Exp Cell Res 317:531-538
30. Nijnik A, Madera L, Ma S, Waldbrook M, Elliott MR, Easton DM, Mayer ML, Mullaly SC, Kindrachuk J, Jenssen Hv, Hancock REW (2010) Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J Immunol 184:2539-2550
31. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A (2004) Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 172:1169-1176 (Pubitemid 38113778)
32. Pence MA, Rooijakkers SHM, Cogen AL, Cole JN, Hollands A, Gallo RL, Nizet V (2010) Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 Group A Streptococcus. J Innate Immun 2:587-595
33. Frick I-M, Akesson P, Rasmussen M, Schmidtchen A, Bjorck L (2003) SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J Biol Chem 278:16561-16566 (Pubitemid 36799517)
34. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial p LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-4679 (Pubitemid 39577671)
35. Schmidtchen A, Frick I-M, Andersson E, Tapper H, Björck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46:157-168 (Pubitemid 35238020)
36. Guina T, Yi EC, Wang H, Hackett M, Miller SI (2000) A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to [alpha]-helical antimicrobial peptides. J Bacteriol 182:4077-4086
37. Hui C-Y, Guo Y, He Q-S, Peng L, Wu S-C, Cao H, Huang S-H (2010) Escherichia coli outer membrane protease OmpT confers resistance to urinary cationic peptides. Microbiol Immunol 54:452-459
38. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M (2004) Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 6:269-275 (Pubitemid 38248010)
39. Kocianova S, Vuong C, Yao Y, Voyich JM, Fischer ER, DeLeo FR, Otto M (2005) Key role of poly-c-dl-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J Clin Invest 115:688-694
40. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, De Leo FR, Otto M (2004) A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 279:54881-54886
41. Koprivnjak T, Peschel A, Gelb MH, Liang NS, Weiss JP (2002) Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus. J Biol Chem 277:47636-47644 (Pubitemid 36159285)
42. Koprivnjak T, Weidenmaier C, Peschel A, Weiss JP (2008) Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A2 and human beta-defensin -3. Infect Immun 76:2169-2176 (Pubitemid 351656152)
43. Raetz CRH, Reynolds CM, Trent MS, Bishop RE (2007) Lipid A modification systems in Gram-negative bacteria. Annu Rev Biochem 76:295-329
44. Neuhaus FC, Baddiley J (2003) A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol Mol Biol Rev 67:686-723 (Pubitemid 37549774)
45. Weidenmaier C, Peschel A (2008) Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol 6:276-287 (Pubitemid 351404772)
46. Trent MS, Stead CM, Tran AX, Hankins JV (2006) Invited review: diversity of endotoxin and its impact on pathogenesis. J Endotxin Res 12:205-223 (Pubitemid 47470164)
47. Weidenmaier C, Kokai-Kun JF, Kulauzovic E, Kohler T, Thumm G, Stoll H, Gotz F, Peschel A (2008) Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int J Med Microbiol 298:505-513
48. Baddiley J, Buchanan JG, Hardy FE, Martin RO, Rajbhandary UL, Sanderson AR (1961) The structure of the ribitol teichoic acid of Staphylococcus aureus H. Biochim Biophys Acta 52:406-407
49. Morath S, Geyer A, Hartung T (2001) Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193:393-397 (Pubitemid 32524522)
50. Fischer W (1994) Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus. Med Microbiol Immunol (Berl) 183:61-76
51. Xia G, Kohler T, Peschel A (2009) The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol 300:148-154
52. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Gotz F (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274:8405-8410 (Pubitemid 29164628)
53. Weidenmaier C, Peschel A, Kempf VAJ, Lucindo N, Yeaman MR, Bayer AS (2005) DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun 73:8033-8038 (Pubitemid 41740290)
54. Collins LV, Kristian SA, Weidenmaier C, Faigle M, Van Kessel KP, Van Strijp JA, Gotz F, Neumeister B, Peschel A (2002) Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis 186:214-219 (Pubitemid 34765509)
55. Abachin E, Poyart C, Pellegrini E, Milohanic E, Fiedler F, Berche P, Trieu-Cuot P (2002) Formation of D-alanyl-lipoteichoic acid is required for adhesion and virulence of Listeria monocytogenes. Mol Microbiol 43:1-14 (Pubitemid 34212186)
56. Kovacs M, Halfmann A, Fedtke I, Heintz M, Peschel A, Vollmer W, Hakenbeck R, Bruckner R (2006) A Functional dlt operon, encoding proteins required for incorporation of D-alanine in teichoic acids in Gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae. J Bacteriol 188:5797-5805 (Pubitemid 44384087)
57. Abi Khattar Z, Rejasse A, Destoumieux-Garzon D, Escoubas JM, Sanchis V, Lereclus D, Givaudan A, Kallassy M, Nielsen-Leroux C, Gaudriault S (2009) The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects. J Bacteriol 191:7063-7073
58. Cox KH, Ruiz-Bustos E, Courtney HS, Dale JB, Pence MA, Nizet V, Aziz RK, Gerling I, Price SM, Hasty DL (2009) Inactivation of DltA modulates virulence factor expression in Streptococcus pyogenes. PLoS ONE 4:e5366
59. Haas R, Koch HU, Fischer W (1984) Alanyl turnover from lipoteichoic acid to teichoic acid in Staphylococcus aureus. FEMS Microbiol Lett 21:27-31 (Pubitemid 14163812)
60. Koprivnjak T, Mlakar V, Swanson L, Fournier B, Peschel A, Weiss JP (2006) Cation-induced transcriptional regulation of the dlt operon of Staphylococcus aureus. J Bacteriol 188:3622-3630 (Pubitemid 43726226)
61. Perego M, Glaser P, Minutello A, Strauch MA, Leopold K, Fischer W (1995) Incorporation of D-alanine into lipoteichoic acid and wall teichoic acid in Bacillus subtilis. Identification of genes and regulation. J Biol Chem 270:15598-15606
62. Grundling A, Missiakas DM, Schneewind O (2006) Staphylococcus aureus mutants with increased lysostaphin resistance. J Bacteriol 188:6286-6297 (Pubitemid 44448571)
63. Grundling A, Schneewind O (2006) Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 188:2463-2472
64. Fabretti F, Theilacker C, Baldassarri L, Kaczynski Z, Kropec A, Holst O, Huebner J (2006) Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect Immun 74:4164-4171 (Pubitemid 43993350)
65. Gross M, Cramton SE, Gotz F, Peschel A (2001) Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces. Infect Immun 69:3423-3426 (Pubitemid 32332242)
66. Weidenmaier C, Peschel A, Xiong YQ, Kristian SA, Dietz K, Yeaman MR, Bayer AS (2005) Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 191:1771-1777 (Pubitemid 40656767)
67. Kristian SA, Lauth X, Nizet V, Goetz F, Neumeister B, Peschel A, Landmann R (2003) Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. J Infect Dis 188:414-423 (Pubitemid 36960652)
68. Deininger S, Stadelmaier A, von Aulock S, Morath S, Schmidt RR, Hartung T (2003) Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J Immunol 170:4134-4138 (Pubitemid 36428177)
69. Walter J, Loach DM, Alqumber M, Rockel C, Hermann C, Pfitzenmaier M, Tannock GW (2007) D-alanyl ester depletion of teichoic acids in Lactobacillus reuteri 100-23 results in impaired colonization of the mouse gastrointestinal tract. Environ Microbiol 9:1750-1760 (Pubitemid 46905411)
70. Foreman-Wykert AK, Weinrauch Y, Elsbach P, Weiss J (1999) Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria. J Clin Invest 103:715-721 (Pubitemid 29122425)
71. Weiss J, Inada M, Elsbach P, Crowl RM (1994) Structural determinants of the action against Escherichia coli of a human inflammatory fluid phospholipase A2 in concert with polymorphonuclear leukocytes. J Biol Chem 269:26331-26337 (Pubitemid 24328451)
72. Heptinstall S, Archibald AR, Baddiley J (1970) Teichoic acids and membrane function in bacteria. Nature 225:519-521
73. MacArthur AE, Archibald AR (1984) Effect of culture pH on the D-alanine ester content of lipoteichoic acid in Staphylococcus aureus. J Bacteriol 160:792-793 (Pubitemid 15214302)
74. Hurst A, Hughes A, Duckworth M, Baddiley J (1975) Loss of D-alanine during sublethal heating of Staphylococcus aureus S6 and magnesium binding during repair. J Gen Microbiol 89:277-284
75. Koch HU, Doker R, Fischer W (1985) Maintenance of D-alanine ester substitution of lipoteichoic acid by reesterification in Staphylococcus aureus. J Bacteriol 164:1211-1217 (Pubitemid 16207265)
76. Kiriukhin MY, Neuhaus FC (2001) D-alanylation of lipoteichoic acid: role of the D-alanyl carrier protein in acylation. J Bacteriol 183:2051-2058 (Pubitemid 32226002)
77. Poyart C, Lamy MC, Boumaila C, Fiedler F, Trieu-Cuot P (2001) Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J Bacteriol 183:6324-6334 (Pubitemid 34059406)
78. Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ (2001) Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol 183:7341-7353 (Pubitemid 33121868)
79. Said-Salim B, Dunman PM, McAleese FM, Macapagal D, Murphy E, McNamara PJ, Arvidson S, Foster TJ, Projan SJ, Kreiswirth BN (2003) Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol 185:610-619 (Pubitemid 36070488)
80. Herbert S, Bera A, Nerz C, Kraus D, Peschel A, Goerke C, Meehl M, Cheung A, Gotz F (2007) Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in Staphylococci. PLoS Pathogens 3:e102
81. Meehl M, Herbert S, Gotz F, Cheung A (2007) Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother 51:2679-2689 (Pubitemid 47206200)
82. Kraus D, Herbert S, Kristian SA, Khosravi A, Nizet V, Gotz F, Peschel A (2008) The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses. BMC Microbiol 8:85
83. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M (2007) The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol 66:1136-1147 (Pubitemid 350115022)
84. Otto M (2009) Bacterial sensing of antimicrobial peptides. Contrib Microbiol 16:136-149
85. Peschel A (2001) Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J Exp Med 193:1067-1076
86. Kuroda M, Kuwahara-Arai K, Hiramatsu K (2000) Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun 269:485-490 (Pubitemid 30440327)
87. Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta Biomembranes 1788:1687-1692
88. Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A (2004) MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett 231:67-71 (Pubitemid 38180561)
89. Ernst CM, Staubitz P, Mishra NN, Yang S-J, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A (2009) The Bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog 5:e1000660
90. Friedman L, Alder JD, Silverman JA (2006) Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 50:2137-2145 (Pubitemid 43807536)
91. Rubio A, Conrad M, Haselbeck R, Kedar GC, Driver V, Finn J, Silverman J (2011) Regulation of mprF by antisense restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus. Antimicrob Agents Chemother 55:364-367
92. Yang S-J, Xiong YQ, Dunman PM, Schrenzel J, Francois P, Peschel A, Bayer AS (2009) Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains. Antimicrob Agents Chemother 53:2636-2637
93. Straus SK, Hancock REW (2006) Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biophys Biochim Acta Biomembranes 1758:1215-1223 (Pubitemid 44436068)
94. Camargo ILBdC, Neoh H-M, Cui L, Hiramatsu K (2008) Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob Agents Chemother 52:4289-4299
95. Ruzin A, Severin A, Moghazeh SL, Etienne J, Bradford PA, Projan SJ, Shlaes DM (2003) Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. Biochim Biophys Acta 1621:117-121 (Pubitemid 36515093)
96. Nishi H, Komatsuzawa H, Fujiwara T, McCallum N, Sugai M (2004) Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother 48:4800-4807 (Pubitemid 39577687)
97. Gunn JS, Miller SI (1996) PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J Bacteriol 178:6857-6864 (Pubitemid 26404962)
98. Gunn JS, Lim KB, Krueger J, Kim K, Guo L, Hackett M, Miller SI (1998) PmrA-PmrB-regulated genes necessary for 4-amino-arabinose lipid A modification and polymyxin resistance. Mol Microbiol 27:1171-1182
99. Gunn JS (2001) Bacterial modification of LPS and resistance to antimicrobial peptides. J Endotxin Res 7:57-62
100. Lee H, Hsu F-F, Turk J, Groisman EA (2004) The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J Bacteriol 186:4124-4133 (Pubitemid 38802559)
101. Groisman EA, Heffron F, Solomon F (1992) Molecular genetic analysis of the Escherichia coli phoP locus. J Bacteriol 174:486-491
102. Groisman EA, Chiao E, Lipps CJ, Heffron F (1989) Salmonella typhimurium phoP virulence gene is a transcriptional regulator. Proc Natl Acad Sci USA 86:7077-7081 (Pubitemid 19240869)
103. 2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 84:165-174
104. 2+ sensor PhoQ of Salmonella enterica. J Mol Biol 325:795-807
105. Vescovi EG, Ayala YM, Di Cera E, Groisman EA (1997) Characterization of the bacterial sensor protein PhoQ. Evidence for distinct binding sites for Mg2+ and Ca2+. J Biol Chem 272:1440-1443 (Pubitemid 27043217)
106. Alpuche Aranda CM, Swanson JA, Loomis WP, Miller SI (1992) Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci USA 89:10079-10083
107. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, Klevit RE, Le Moual H, Miller SI (2005) Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122:461-472 (Pubitemid 41127146)
108. Charles RC, Harris JB, Chase MR, Lebrun LM, Sheikh A, La-Rocque RC, Logvinenko T, Rollins SM, Tarique A, Hohmann EL, Rosenberg I, Krastins B, Sarracino DA, Qadri F, Calderwood SB, Ryan ET (2009) Comparative proteomic analysis of the phoP regulon in Salmonella enterica serovar typhi versus typhimurium. PLoS ONE 4:e6994
109. Prost LR, Sanowar S, Miller SI (2007) Salmonella sensing of anti-microbial mechanisms to promote survival within macrophages. Immunol Rev 219:55-65 (Pubitemid 47390009)
110. Guo L, Lim KB, Gunn JS, Bainbridge B, Darveau RP, Hackett M, Miller SI (1997) Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253
111. Miller SI, Pulkkinen WS, Selsted ME, Mekalanos JJ (1990) Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun 58:3706-3710 (Pubitemid 20353372)
112. Prost LR, Daley ME, Bader MW, Klevit RE, Miller SI (2008) The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis. Mol Microbiol 69:503-519 (Pubitemid 351988020)
113. Bayer AS, Prasad R, Chandra J, Koul A, Smriti M, Varma A, Skurray RA, Firth N, Brown MH, Koo S-P, Yeaman MR (2000) In Vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect Immun 68:3548-3553
114. Mishra NN, Liu GY, Yeaman MR, Nast CC, Proctor RA, McKinnell J, Bayer AS (2011) Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob Agents Chemother 55:526-531
115. Bengoechea JA, Skurnik M (2000) Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol Microbiol 37:67-80 (Pubitemid 30479358)
116. Tzeng Y-L, Ambrose KD, Zughaier S, Zhou X, Miller YK, Shafer WM, Stephens DS (2005) Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol 187:5387-5396 (Pubitemid 41022958)
117. Shafer WM, Qu X, Waring AJ, Lehrer RI (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc Natl Acad Sci USA 95:1829-1833 (Pubitemid 28103479)
118. Rieg S, Huth A, Kalbacher H, Kern WV (2008) Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Int J Antimicrob Ag 33:174-176
119. Bayer AS, Kupferwasser LI, Brown MH, Skurray RA, Grkovic S, Jones T, Mukhopadhay K, Yeaman MR (2006) Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 In Vitro associated with qacA gene carriage is independent of multidrug efflux pump activity. Antimicrob Agents Chemother 50:2448-2454 (Pubitemid 43993185)
120. May JJ, Finking R, Wiegeshoff F, Weber TT, Bandur N, Koert U, Marahiel MA (2005) Inhibition of the D-alanine:D-alanyl carrier protein ligase from Bacillus subtilis increases the bacterium's susceptibility to antibiotics that target the cell wall. FEBS 272:2993-3003 (Pubitemid 40904687)
121. Peschel A (2002) How do bacteria resist human antimicrobial peptides? Trend Microbiol 10:179-186
122. Jin T, Bokarewa M, McIntyre L, Tarkowski A, Corey GR, Reller LB, Fowler VG Jr (2003) Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 52:919-923 (Pubitemid 37297324)
123. Kwiecinski J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T, Jin T, Bokarewa M (2010) Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis 202:1041-1049
124. Belas R, Manos J, Suvanasuthi R (2004) Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun 72:5159-5167 (Pubitemid 39223401)
125. Johansson L, Thulin P, Sendi P, Hertzen E, Linder A, Akesson P, Low DE, Agerberth B, Norrby-Teglund A (2008) Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humans. Infect Immun 76:3399-3404
126. Woods DE, Cryz SJ, Friedman RL, Iglewski BH (1982) Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun 36:1223-1228 (Pubitemid 12124844)
127. Blackwood LL, Stone RM, Iglewski BH, Pennington JE (1983) Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection. Infect Immun 39:198-201 (Pubitemid 13212515)
128. Rupp ME, Ulphani JS, Fey PD, Bartscht K, Mack D (1999) Characterization of the importance of polysaccharide intercellular adhesin/Hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect Immun 67:2627-2632 (Pubitemid 29200530)
129. Rupp ME, Fey PD, Heilmann C, Gotz F (2001) Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J Infect Dis 183:1038-1042 (Pubitemid 32230951)
130. Jones A, Georg M, Maudsdotter L, Jonsson A-B (2009) Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J Bacteriol 191:3861-3868
131. Yi K, Stephens DS, Stojiljkovic I (2003) Development and evaluation of an improved mouse model of meningococcal colonization. Infect Immun 71:1849-1855 (Pubitemid 36368715)
132. Spinosa MR, Progida C, Tala A, Cogli L, Alifano P, Bucci C (2007) The Neisseria meningitidis capsule is important for intracellular survival in human cells. Infect Immun 75:3594-3603 (Pubitemid 47040962)
133. Cortes G, Borrell N, de Astorza B, Gomez C, Sauleda J, Alberti S (2002) Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70:2583-2590 (Pubitemid 34408403)
134. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72:7107-7114 (Pubitemid 39552380)
135. Llobet E, Tomas JM, Bengoechea JA (2008) Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154:3877-3886
136. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A (2004) Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med 10:243-245 (Pubitemid 38667612)
137. Kristian SA, Datta V, Weidenmaier C, Kansal R, Fedtke I, Peschel A, Gallo RL, Nizet V (2005) D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion. J Bacteriol 187:6719-6725 (Pubitemid 41356245)
138. Kristian SA, Durr M, Van Strijp JAG, Neumeister B, Peschel A (2003) MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun 71:546-549 (Pubitemid 36026063)
139. Gunn JS, Ryan SS, Van Velkinburgh JC, Ernst RK, Miller SI (2000) Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and Oral virulence of Salmonella enterica serovar typhimurium. Infect Immun 68:6139-6146
140. Zhou Z, Ribeiro AA, Lin S, Cotter RJ, Miller SI, Raetz CRH (2001) Lipid A modifications in polymyxin-resistant Salmonella typhimurium. J Biol Chem 276:43111-43121
141. Belden WJ, Miller SI (1994) Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci. Infect Immun 62:5095-5101 (Pubitemid 24332819)
142. Guo L (1998) Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95:189-198
143. Pelz A, Wieland K-P, Putzbach K, Hentschel P, Albert K, Gotz F (2005) Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem 280:32493-32498 (Pubitemid 41361862)
144. Clauditz A, Resch A, Wieland K-P, Peschel A, Gotz F (2006) Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 74:4950-4953 (Pubitemid 44157287)
145. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, Fierer J, Nizet V (2005) Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202:209-215 (Pubitemid 41043816)
146. Kupferwasser LI, Skurray RA, Brown MH, Firth N, Yeaman MR, Bayer AS (1999) Plasmid-mediated resistance to thrombin-induced platelet microbicidal protein in Staphylococci: role of the qacA locus. Antimicrob Agents Chemother 43:2395-2399 (Pubitemid 29471216)
147. Warner DM, Folster JP, Shafer WM, Jerse AE (2007) Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae. J Infect Dis 196:1804-1812 (Pubitemid 351411941)
148. Jerse AE, Sharma ND, Simms AN, Crow ET, Snyder LA, Shafer WM (2003) A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect Immun 71:5576-5582 (Pubitemid 37205608)